logo
Home  > methyl (1'R,2S,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate

AD44331

107724-20-9 | methyl (1'R,2S,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate

Packsize Purity Availability Price Discounted Price    Quantity
5mg 98% in stock $80.00 $56.00 -   +
1g 98% in stock $110.00 $77.00 -   +
5g 98% in stock $403.00 $282.00 -   +
25g 98% in stock $1,954.00 $1,368.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Request Bulk Quote
Description
Catalog Number: AD44331
Chemical Name: methyl (1'R,2S,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate
CAS Number: 107724-20-9
Molecular Formula: C24H30O6
Molecular Weight: 414.4914
MDL Number: MFCD07783647
SMILES: COC(=O)[C@@H]1CC2=CC(=O)CC[C@@]2([C@@]23[C@@H]1[C@@H]1CC[C@@]4([C@@]1(C)C[C@H]3O2)OCC(=O)C4)C

 

Computed Properties
Complexity: 907  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 8  
Heavy Atom Count: 30  
Hydrogen Bond Acceptor Count: 6  
Rotatable Bond Count: 2  
XLogP3: 1.4  

 

 

Upstream Synthesis Route 
  • Eplerenone, a selective aldosterone antagonist, is a valuable compound in chemical synthesis due to its unique reactivity and specificity in inhibiting the actions of aldosterone in the body. In the realm of organic chemistry, Eplerenone can be utilized to study and manipulate various chemical reactions that involve aldosterone receptors, providing a valuable tool for researchers and scientists in exploring the mechanisms of aldosterone-related processes. By incorporating Eplerenone into chemical synthesis studies, researchers can gain deeper insights into the complex interactions of aldosterone and potentially develop novel strategies for treating conditions related to aldosterone dysregulation. In addition, Eplerenone's ability to selectively target aldosterone receptors offers a promising avenue for the design and development of new drugs with improved specificity and efficacy in clinical applications.
Literature
FEATURED PRODUCTS